Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
Congratulations! The leading enterprises and figures in high-quality development in 2022 have been announced! Dr. Jin Fang, chief scientist of HealthGen, has been selected.
Published Time：
2022-11-08
Driving high-quality development is Shenzhen's mission and responsibility. On November 7, the leading enterprises and figures in high-quality development in 2022 were announced! Dr. Jin Fang, chief scientist of HealthGen, was among them.
High-quality development is development that can well meet the people's ever-growing needs for a better life, development that embodies the new development philosophy, and development where innovation becomes the primary driving force, coordination becomes an inherent characteristic, green becomes a universal form, openness becomes the only way, and sharing becomes the fundamental goal. Guided by the Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era, we will thoroughly implement the important speeches and instructions of the Party, base ourselves on the new stage of development, implement the new development philosophy, build a new development pattern, and promote high-quality development.
Coming to Shenzhen Science and Technology Park, there is a vibrant atmosphere. Jin Fang, chief scientist of Joincare Pharmaceutical Group Industry Co., Ltd., said with deep feeling that as a comprehensive pharmaceutical group rooted in domestic manufacturing, HealthGen earnestly studies and understands the spirit of the 20th National Congress of the Communist Party of China, keeps in mind its mission of serving the people's livelihood, focuses on solving the clinical medication needs of ordinary people, and contributes to the construction of a "Healthy China".
In the past, we could only survive under the rules set by the international community, but in the great practice of China's reform and opening up, especially since the 18th National Congress of the Communist Party of China, our scientific and technological strength has continuously increased, the business environment has been further optimized, and enterprises have been revitalized. HealthGen has made significant R&D investments, broken foreign companies' monopolies, and gradually overcome "bottlenecks" in the sub-sector with multiple high-quality inhalation products. We have gradually broken the international market monopoly in respiratory medication, successfully covering all categories of asthma and COPD inhalation treatment drugs in existing and under-research varieties, and rapidly opening up and covering the domestic market, providing Chinese patients with better and cheaper drug choices.
Jin Fang specifically mentioned that HealthGen, through 2 years and 39 days of day and night efforts, overcame numerous difficulties and finally developed the high-protection rate recombinant protein vaccine, Lizhu Likang V-01, which has now been granted emergency authorization for use, providing more high-quality options for China's epidemic prevention efforts. "I believe that in the future, through self-reliance in science and technology, we can use our scientific strength to develop better technological products and protect the lives and health of the people."
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.